Nearly 8 million people die of cancer each year, worldwide. Knowledge of how cancer cells behave at the molecular and cellular level continues to expand, and a greater understanding of the pathways and molecular changes that occur in cancer cells is leading to advances in patient care. Ensuring that the next generation of cancer researchers are developing not just the skills to perform high caliber basic research, but a deep appreciation for the disease as clinicians see it, is critical for bridging the divide between benc and bedside. To address this need, we have developed the current iteration of the Cancer Biology Training Grant (CBTG), now in its 22nd year of funding. The CBTG will support trainees at the Case Comprehensive Cancer Center (Case CCC), a matrix center comprised of Case Western Reserve University (CWRU), University Hospitals Case Medical Center, and the Cleveland Clinic. The CBTG emphasizes rigorous training in basic cancer- related laboratory research, enriched by educational forums that address important topics in clinical and translational cancer research. The four pillars of the CBTG include: (1) laboratory research and scientific interactions; (2) classroom curriculum; (3) a clinical perspective; and (4) career development and professional enrichment programs. Laboratory research will take place in one of the 19 trainers' laboratories, and include a number of elements aimed at facilitating scientific interaction. The classroom curriculum provides a solid foundation in cancer biology instruction. The clinical perspective is a new initiative to expose trainees to important elements of clinical and translational science. It includes participation in genomics tumor board, an introductory course on clinical research, training in the use of human subjects in research, exposure to IRB and clinical trial design, as well as the shadowing of physician-scientists. Increased exposure of trainees to clinical research will prepare trainees to communicate and interact with clinicians, thereby intertwining basic research and clinical science to bridge the bench-to-bedside divide. The career development and professional enrichment module ensures that trainees are developing the skills necessary to achieve their expressed career goals in research. Training in the CBTG will provide the fundamental skills necessary for outstanding careers in biomedical cancer research, together with a deep appreciation of the challenges and complexity of cancer in the clinical setting.

Public Health Relevance

The Cancer Biology Training Grant provides trainees with the fundamental skills necessary for outstanding careers in biomedical cancer research together with an appreciation of the challenges and complexity of cancer in the clinical setting. The training program emphasizes rigorous training in basic cancer-related laboratory research enriched by educational forums that address important topics in clinical and translational cancer research and career development.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA059366-24
Application #
9773626
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Damico, Mark W
Project Start
1993-06-01
Project End
2021-06-30
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
24
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Pathology
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Barker, Emily C; Kim, Byung-Gyu; Yoon, Ji Hee et al. (2018) Potent suppression of both spontaneous and carcinogen-induced colitis-associated colorectal cancer in mice by dietary celastrol supplementation. Carcinogenesis 39:36-46
Reinartz, Roman; Wang, Shanshan; Kebir, Sied et al. (2017) Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma. Clin Cancer Res 23:562-574
Samaeekia, Ravand; Adorno-Cruz, Valery; Bockhorn, Jessica et al. (2017) miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway. Clin Cancer Res 23:1091-1103
Sahni, Jennifer M; Gayle, Sylvia S; Webb, Bryan M et al. (2017) Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors. Cancer Res 77:5395-5408
Seachrist, Darcie D; Sizemore, Steven T; Johnson, Emhonta et al. (2017) Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer. Breast Cancer Res 19:66
Zhao, Yiqing; Scott, Anthony; Zhang, Peng et al. (2017) Regulation of paxillin-p130-PI3K-AKT signaling axis by Src and PTPRT impacts colon tumorigenesis. Oncotarget 8:48782-48793
Bryson, Benjamin L; Junk, Damian J; Cipriano, Rocky et al. (2017) STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence. Cell Cycle 16:319-334
Gayle, Sylvia S; Sahni, Jennifer M; Keri, Ruth A (2017) BETi induction of mitotic catastrophe: towing the LIN9. Oncoscience 4:128-130
Junk, D J; Bryson, B L; Smigiel, J M et al. (2017) Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling. Oncogene 36:4001-4013
Doherty, Mary R; Smigiel, Jacob M; Junk, Damian J et al. (2016) Cancer Stem Cell Plasticity Drives Therapeutic Resistance. Cancers (Basel) 8:

Showing the most recent 10 out of 82 publications